CD5 POSITIVE

Clinical trials for CD5 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new CD5 POSITIVE trials appear

Sign up with your email to follow new studies for CD5 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

Anti-Inflammatory drug may boost chemo for aggressive lymphoma

Disease control Not yet recruiting

This phase 2 trial tests whether adding the anti-inflammatory drug celecoxib to standard R-CHOP chemotherapy improves outcomes for people with newly diagnosed, advanced CD5-positive diffuse large B-cell lymphoma (a fast-growing type). Sixty participants will be randomly assigned …

Matched conditions: CD5 POSITIVE

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

CD5 POSITIVE

Get alerted when new CD5 POSITIVE trials appear

Anti-Inflammatory drug may boost chemo for aggressive lymphoma